Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 8,245 | 6,987 | 995 | 411 | 0 |
| Operating Income | -8,245 | -6,987 | -995 | -411 | N/A |
| Interest Expense | 0 | 1,167 | 145 | 10 | 0 |
| Other Income | -347 | -3,477 | 0 | 0 | 0 |
| Pre-tax Income | -8,591 | -11,631 | -1,140 | -420 | 0 |
| Net Income Continuous | -8,591 | -11,631 | -1,140 | -420 | N/A |
| Net Income | $-8,591 | $-11,631 | $-1,140 | $-420 | $N/A |
| EPS Basic Total Ops | -21.75 | -61.00 | -8.75 | -3.25 | N/A |
| EPS Basic Continuous Ops | -21.80 | -61.10 | -8.73 | -3.22 | N/A |
| EPS Diluted Total Ops | -21.75 | -61.00 | -8.75 | -3.25 | N/A |
| EPS Diluted Continuous Ops | -21.80 | -61.10 | -8.73 | -3.22 | N/A |
| EPS Diluted Before Non-Recurring Items | -21.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,244 | $-6,634 | $-893 | $-410 | $N/A |